European CHMP recommends approval of generic lenalidomide

Studies have demonstrated the satisfactory quality of Lenalidomide Krka, Lenalidomide Krka d.d. and Lenalidomide Krka d.d Novo mestro and their bioequivalence to the reference product Revlimid.

Source:

European Medicines Agency